Location History:
- Praha, CZ (2004)
- Prague, CZ (2005)
Company Filing History:
Years Active: 2004-2005
Title: Radim Scigel: Innovator in Pharmaceutical Chemistry
Introduction
Radim Scigel is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the resolution of tamsulosin. With a total of 2 patents to his name, Scigel's work has implications for the development of optically pure compounds.
Latest Patents
Scigel's latest patents focus on the process for the resolution of tamsulosin and related compounds. His innovative approach allows for the separation of optically impure tamsulosin, including racemic tamsulosin, into optically pure (R)- or (S)-tamsulosin. This is achieved through the use of diastereomeric sulfonate salts of tamsulosin in a fractional crystallization technique. Additionally, he provides a method for obtaining racemic tamsulosin free base in solid form, which includes two crystalline polymorphic forms.
Career Highlights
Throughout his career, Radim Scigel has worked with prominent companies in the pharmaceutical industry, including Synthon IP Inc. and Synthon B.V. His expertise in the field has allowed him to contribute to various projects that enhance the efficacy and purity of pharmaceutical compounds.
Collaborations
Scigel has collaborated with esteemed colleagues such as Hans Jan Hoorn and Theodorus H A Peters. These partnerships have further enriched his research and development efforts in pharmaceutical chemistry.
Conclusion
Radim Scigel's contributions to the field of pharmaceutical chemistry, particularly through his patents on tamsulosin resolution, highlight his innovative spirit and dedication to advancing drug development. His work continues to influence the industry and pave the way for future advancements.